Trial Profile
A phase 2 study of ABI-1968 in subjects with high grade cervical intraepithelial neoplasia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2018
Price :
$35
*
At a glance
- Drugs ABI 1968 (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Therapeutic Use
- 13 Jul 2018 New trial record
- 10 Jul 2018 According to an Antiva Biosciences media release, the company expects to start this study in the second half of 2019.